0.232EUR
59.32 MEUR
6.59 BEUR
291.30 M
About GRIFOLS SA INH. A EO-,25
Sector
CEO
Nacho Abia
Headquarters
Barcelona
Website
Employees (FY)
23.74 K
Founded
1940
ISIN
ES0171996087
FIGI
BBG000PL3RP5
Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange GRIFOLS SA INH. A EO-,25 stocks are traded under the ticker OZTA.
GRIFOLS SA INH. A EO-,25 is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for GRIFOLS SA INH. A EO-,25 has a max estimate of 27.800 EUR and a min estimate of 6.200 EUR.
OZTA earnings for the last quarter are 0.14 EUR per share, whereas the estimation was 0.19 EUR resulting in a −26.11% surprise. The estimated earnings for the next quarter are 0.20 EUR per share. See more details about GRIFOLS SA INH. A EO-,25 earnings.
GRIFOLS SA INH. A EO-,25 revenue for the last quarter amounts to 1.49 B EUR despite the estimated figure of 1.59 B EUR. In the next quarter revenue is expected to reach 1.77 B EUR.
Yes, you can track GRIFOLS SA INH. A EO-,25 financials in yearly and quarterly reports right on TradingView.
OZTA net income for the last quarter is 55.99 M EUR, while the quarter before that showed 59.54 M EUR of net income which accounts for −5.96% change. Track more GRIFOLS SA INH. A EO-,25 financial stats to get the full picture.
GRIFOLS SA INH. A EO-,25 dividend yield was 0% in 2023, and payout ratio reached 0%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, OZTA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GRIFOLS SA INH. A EO-,25 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 23.74 K employees. See our rating of the largest employees — is GRIFOLS SA INH. A EO-,25 on this list?
We've gathered analysts' opinions on GRIFOLS SA INH. A EO-,25 future price: according to them, OZTA price has a max estimate of 27.80 EUR and a min estimate of 6.20 EUR. Read a more detailed GRIFOLS SA INH. A EO-,25 forecast: see what analysts think of GRIFOLS SA INH. A EO-,25 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GRIFOLS SA INH. A EO-,25 EBITDA is 1.30 B EUR, and current EBITDA margin is 17.90%. See more stats in GRIFOLS SA INH. A EO-,25 financial statements.